menopause and semaglutide Interesting article comparing use in postmenopausal women on, HRT vs. not on HRT, Results not surprising:, · Women on HRT semaglutide had 30 % more weight loss than those not on HRT, · Semaglutide Review: 'The Drug Helped

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

The FDA has received more than 215 reports of adverse events related to compounded tirzepatide

The SCALE Obesity and Prediabetes trial (N=3,731) showed participants who discontinued liraglutide 3.0 mg after 56 weeks regained roughly 50% of their lost weight within 12 weeks [1]

Reserved for adults

Notably, the severity of acute COVID-19 infection affects the development of neuropsychiatric symptoms, with ICU survivors being more likely (56%) than non-ICU survivors to develop a neuropsychiatric condition [24]